Literature DB >> 21747238

Reducing tuberculosis-associated early mortality in antiretroviral treatment programmes in sub-Saharan Africa.

Stephen D Lawn, Anthony D Harries.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21747238     DOI： 10.1097/QAD.0b013e328348fb61

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

Review 1.  Tuberculous pericarditis with and without HIV.

Authors:  Mpiko Ntsekhe; Bongani M Mayosi
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

2.  When smear and molecular diagnostics fail: identification of tuberculosis in advanced HIV infection using the newly developed urine lipoarabinomannan lateral-flow assay.

Authors:  Ashar Vijay Dhana; Pauline Howell; David Spencer
Journal:  BMJ Case Rep       Date:  2014-03-10

3.  Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire.

Authors:  A F Auld; M Z Tuho; K A Ekra; J Kouakou; R W Shiraishi; G Adjorlolo-Johnson; R Marlink; T V Ellerbrock
Journal:  Int J Tuberc Lung Dis       Date:  2014-04       Impact factor: 2.373

4.  Adaptive pair-matching in randomized trials with unbiased and efficient effect estimation.

Authors:  Laura B Balzer; Maya L Petersen; Mark J van der Laan
Journal:  Stat Med       Date:  2014-11-25       Impact factor: 2.373

Review 5.  Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Graeme Meintjes; Haileyesus Getahun; Diane V Havlir; Robin Wood
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177

6.  Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality.

Authors:  Andrew F Auld; Tefera Agizew; Sherri Pals; Alyssa Finlay; Ndwapi Ndwapi; Rosanna Boyd; Heather Alexander; Anikie Mathoma; Joyce Basotli; Sambayawo Gwebe-Nyirenda; James Shepherd; Tedd V Ellerbrock; Anand Date
Journal:  BMC Infect Dis       Date:  2016-10-26       Impact factor: 3.090

7.  Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.

Authors:  Margaret L McNairy; Elaine J Abrams; Miriam Rabkin; Wafaa M El-Sadr
Journal:  PLoS Med       Date:  2017-04-18       Impact factor: 11.069

8.  Incidence of Tuberculosis During the First Year of Antiretroviral Treatment in West African HIV-Infected Adults.

Authors:  Boris Tchakounte Youngui; Patrick Coffie; Eugène Messou; Armel Poda; Louise Fortes Deguenonvo; Denise Hawerlander; Albert Minga; Eric Balestre; François Dabis; Olivier Marcy
Journal:  Open Forum Infect Dis       Date:  2020-06-02       Impact factor: 3.835

9.  Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.

Authors:  Lucy Mupfumi; Sikhulile Moyo; Kesaobaka Molebatsi; Prisca K Thami; Motswedi Anderson; Tuelo Mogashoa; Thato Iketleng; Joseph Makhema; Richard Marlink; Ishmael Kasvosve; Max Essex; Rosemary M Musonda; Simani Gaseitsiwe
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.